← Open Payments lookup

VADIM BARAM: Open Payments

NPI 1124007380 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$517,139 in 1,079 payments from 22 companies in 2025. Trend: 2023 $352,097 · 2024 $199,763 · 2025 $517,139

Speaker / faculty: $408,810Travel & lodging: $59,886Food & beverage: $21,635Consulting: $19,613Speaker / faculty: $7,088Education: $108
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.380$249,562
Alkermes, Inc.147$94,449
E.R. Squibb & Sons, L.L.C.113$69,494
Teva Pharmaceuticals USA, Inc.125$66,269
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)76$18,180
Noven Therapeutics, LLC17$8,300
ACADIA Pharmaceuticals Inc22$6,163
Neurocrine BioSciences, Inc.61$1,226
ABBVIE INC.36$976
Axsome Therapeutics, Inc.32$772

Products named: FANAPT, COBENFY, LYBALVI, UZEDY, ARISTADA, AUSTEDO XR, CAPLYTA, Xelstrym.

Industry payments across MO — which companies pay providers there.